A company can only ride the tide if it stays in business. And it can only stay in business if it has the funds to do so.
Virax's cash position is so weak that even its auditors have expressed concern as to the company's ability to continue as a going concern.
All the positive sentiment in the world regarding immunotherapy counts for nought if you have no cash in the bank.
Add to My Watchlist
What is My Watchlist?
